{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:15:48Z","timestamp":1777385748330,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Contraception"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1023\/a:1006559124829","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T02:18:38Z","timestamp":1040523518000},"page":"1-13","source":"Crossref","is-referenced-by-count":11,"title":["Adverse effects associated with contraceptive implants: incidence, prevention and management"],"prefix":"10.1007","volume":"14","author":[{"given":"K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.C.","family":"Chye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"164253_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/07853899309164160","volume":"25","author":"HB. Croxatto","year":"1993","unstructured":"Croxatto HB. Norplant: Levonorgestrel-releasing contraceptive implant. Ann Med. 1993;25:155-60.","journal-title":"Ann Med."},{"key":"164253_CR2","first-page":"271","volume-title":"Current Issues in Obstetrics and Gynaecology","author":"SJ. Segal","year":"1996","unstructured":"Segal SJ. Contraceptive implants. In: Arulkumaran S, Ng SC, eds. Current Issues in Obstetrics and Gynaecology. Singapore: Oxford University Press; 1996:271-82."},{"key":"164253_CR3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0029-7844(94)00457-O","volume":"85","author":"DK Wysowski","year":"1995","unstructured":"Wysowski DK, Green L. Serious adverse events in Norplant users reported to the Food and Drug Administrations Med Watch Spontaneous Reporting System. Obstet Gynaecol. 1995;85:538-42.","journal-title":"Obstet Gynaecol."},{"key":"164253_CR4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0010-7824(95)00264-2","volume":"53","author":"J Diaz","year":"1996","unstructured":"Diaz J, Faundes A, Olmos P, Diaz M. Bleeding complaints during the first year of Norplant use and their impact on removal rate. Contraception. 1996;53:91-5.","journal-title":"Contraception"},{"key":"164253_CR5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0010-7824(94)90047-7","volume":"50","author":"SA Pasquale","year":"1994","unstructured":"Pasquale SA, Knuppel RA, Owens AG, Bachmann GA. Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users. Contraception. 1994;50:109-16.","journal-title":"Contraception"},{"key":"164253_CR6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00006250-199102000-00018","volume":"77","author":"D Shoupe","year":"1991","unstructured":"Shoupe D, Mishell DR, Bopp BL, Fielding M. The significance of bleeding patterns in Norplant implant users. Obstet Gynecol. 1991;77:256-60.","journal-title":"Obstet Gynecol."},{"key":"164253_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2307\/1966493","volume":"19","author":"I. Sivin","year":"1998","unstructured":"Sivin I. International experience with Norplant and Norplant-2 contraceptives. Stud Fam Plann. 1998;19:81-94.","journal-title":"Stud Fam Plann."},{"key":"164253_CR8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0010-7824(89)90109-1","volume":"39","author":"SA Balogh","year":"1989","unstructured":"Balogh SA, Klavon SL, Basnayake S, Puertollano N, Ramos RM, Grubb GS. Bleeding patterns and acceptability among Norplant users in two Asian countries. Contraception. 1989;39:541-53.","journal-title":"Contraception"},{"key":"164253_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0010-7824(95)00012-Y","volume":"51","author":"S Datey","year":"1995","unstructured":"Datey S, Gaur LN, Saxena BN. Vaginal bleeding patterns of women using different contraceptive methods-An Indian experience. Contraception. 1995;51:155-65.","journal-title":"Contraception"},{"key":"164253_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01850722","volume":"7","author":"A Faundes","year":"1991","unstructured":"Faundes A, Avarez F, Brache V, Jimenez E, Tejada AS. Hormonal changes associated with bleeding during low dose progestagen contraception delivered by Norplant subdermal implants. Adv Contracept. 1991;7:1-10.","journal-title":"Adv Contracept."},{"key":"164253_CR11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0002-9378(96)70326-5","volume":"174","author":"F Alvarez-Sanchez","year":"1996","unstructured":"Alvarez-Sanchez F, Brache V, Thevenin F, Cochon L, Faundes A. Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol. 1996;174:919-22.","journal-title":"Am J Obstet Gynecol."},{"key":"164253_CR12","volume-title":"A Summary of Scientific Data","author":"S Waldman","year":"1990","unstructured":"Waldman S et al. Norplant Levonorgestrel Implants. A Summary of Scientific Data. New York, NY: The Population Council. 1990."},{"key":"164253_CR13","unstructured":"Mishell DR. Overview of contraception. In: Wallace EE, Zucker HA, eds. Reproductive Medicine and Surgery. Baltimore, MD, USA: Moseby; 1995:289-316."},{"key":"164253_CR14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2307\/1966714","volume":"21","author":"PD Darney","year":"1990","unstructured":"Darney PD, Atkinson E, Tanner S, MacPherson S, Hellerstein S, Alvarado A. Acceptance and perceptions of Norplants users in San Francisco, USA. Stud Fam Plann. 1990;21:152-62.","journal-title":"Stud Fam Plann."},{"key":"164253_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0010-7824(93)90091-K","volume":"47","author":"VE. Cullins","year":"1993","unstructured":"Cullins VE. Preliminary experience with Norplant in an inner city population. Contraception. 1993;47:193-203.","journal-title":"Contraception"},{"key":"164253_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0010-7824(93)90081-H","volume":"48","author":"UD Croshy","year":"1993","unstructured":"Croshy UD, Schwarz BE, Gluck KL, Heartwell SE. A preliminary report of Norplant implant insertion in large urban family planning program. Contraception. 1993;48:359-66.","journal-title":"Contraception"},{"key":"164253_CR17","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0002-9378(94)05016-7","volume":"170","author":"PD. Darney","year":"1994","unstructured":"Darney PD. Hormonal implants: Contraception for a new century. Am J Obstet Gynecol. 1994;170:1536-43.","journal-title":"Am J Obstet Gynecol."},{"key":"164253_CR18","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/oxfordjournals.humrep.a138341","volume":"9","author":"I. Sivin","year":"1994","unstructured":"Sivin I. Contraception with Norplant implants. Hum Reprod. 1994;9:1818-26.","journal-title":"Hum Reprod."},{"key":"164253_CR19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0010-7824(95)00189-H","volume":"52","author":"LL Moore","year":"1995","unstructured":"Moore LL, Valuck R, McDougall C, Fink W. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants and oral contraceptives. Contraception. 1995;52:215-20.","journal-title":"Contraception"},{"key":"164253_CR20","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0002-9378(72)90811-3","volume":"112","author":"WN Spellacy","year":"1972","unstructured":"Spellacy WN, Birk SA. The effect of intrauterine devices, oral contraceptives, oestrogens and progestogens on blood pressure. Am J Obstet Gynecol. 1972;112:912-19.","journal-title":"Am J Obstet Gynecol."},{"key":"164253_CR21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0002-9378(80)90860-1","volume":"136","author":"WD Hall","year":"1980","unstructured":"Hall WD, Doublas MB, Blumenstein BA, Hatcher RA. Blood pressure and oral progestational agents: a prospective study of 119 black women. Am J Obstet Gynecol. 1980;136:344-8.","journal-title":"Am J Obstet Gynecol."},{"key":"164253_CR22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0010-7824(94)90049-3","volume":"50","author":"Q. Shen","year":"1994","unstructured":"Shen Qifong, Lin Deliang, Jian Xiurong, Li Haifong, Zhang Zhongshu. Blood pressure changes and hormonal contraceptives. Contraception. 1994;50:131-41.","journal-title":"Contraception"},{"issue":"4","key":"164253_CR23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00003081-199538040-00021","volume":"38","author":"H. Hatasaka","year":"1995","unstructured":"Hatasaka H. Implantable levonorgestrel contraception: 4 years of experience with Norplant. Clin Obstet Gynaecol. 1995;38(4):859-71.","journal-title":"Clin Obstet Gynaecol."},{"key":"164253_CR24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0010-7824(95)00078-O","volume":"51","author":"LA. Nelson","year":"1995","unstructured":"Nelson LA. Neutralizing pH of lidocaine reduces pain during Norplant system insertion procedures. Contraception. 1995;51:299-301.","journal-title":"Contraception"},{"key":"164253_CR25","volume-title":"A Clinical Guide for Contraception","author":"L Speroff","year":"1992","unstructured":"Speroff L, Darney P. Long-acting steroids methods. In: A Clinical Guide for Contraception. Baltimore, Maryland: Williams and Wilkins; 1992."},{"key":"164253_CR26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0010-7824(96)00004-2","volume":"53","author":"SP Sarma","year":"1996","unstructured":"Sarma SP, Wamsher JG, Whitlock SW. Removal of deeply inserted, nonpalpable levonorgestrel (Norplant) implants. Contraception. 1996;53:159-61.","journal-title":"Contraception"},{"key":"164253_CR27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-9378(11)91461-6","volume":"167","author":"DM Twickler","year":"1992","unstructured":"Twickler DM, Schwarz BG. Imaging of the levonorgestrel implantable contraceptive device. Am J Obstet Gynecol. 1992;167:572-3.","journal-title":"Am J Obstet Gynecol."},{"key":"164253_CR28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0010-7824(91)90013-6","volume":"44","author":"J Diaz","year":"1991","unstructured":"Diaz J, Rubin J, Faundes A et al. Comparison of local signs and symptoms after the insertion of Norplant implants with and without a scalpel. Contraception. 1991;44:217-21.","journal-title":"Contraception"},{"key":"164253_CR29","first-page":"613","volume":"34","author":"TJ Zuber","year":"1992","unstructured":"Zuber TJ, DeWitt DE, Patton DD. Skin damage associated with the Norplant contraceptive. J Fam Pract. 1992;34:613-16.","journal-title":"J Fam Pract."},{"key":"164253_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0010-7824(90)90124-E","volume":"41","author":"SL Klavon","year":"1990","unstructured":"Klavon SL, Grubb GS. Insertion site complications during the first year of Norplant use. Contraception. 1990;41:27-37.","journal-title":"Contraception"},{"key":"164253_CR31","first-page":"1293","volume":"153","author":"MJ Alfa","year":"1995","unstructured":"Alfa MJ, Sisler JJ, Harding GKM. Mycobacterium abscessus infection of a Norplant contraceptive implant site. Can Med Assoc. 1995;153:1293-6.","journal-title":"Can Med Assoc."},{"key":"164253_CR32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0010-7824(92)90132-D","volume":"46","author":"J Konje","year":"1992","unstructured":"Konje J, Odukuya O, Otolorin E, Ewings P, Ladipo O. Carbohydrate metabolism before and after Norplant removal. Contraception. 1992;46:61-9.","journal-title":"Contraception"},{"key":"164253_CR33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9378(92)91819-V","volume":"166","author":"J Konje","year":"1992","unstructured":"Konje J, Otolorin E, Ladipo O. The effect of continuous subdermal levonorgestrel (Norplant) on carbohydrate metabolism. Am J Obstet Gynecol. 1992;166:15-19.","journal-title":"Am J Obstet Gynecol."},{"key":"164253_CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0010-7824(91)90116-W","volume":"44","author":"J Konje","year":"1991","unstructured":"Konje J, Otolorin E, Ladipo OA. Changes in carbohydrate metabolism during 30 months of Norplant. Contraception. 1991;44:163-72.","journal-title":"Contraception"},{"key":"164253_CR35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0010-7824(92)90048-X","volume":"45","author":"K Singh","year":"1992","unstructured":"Singh K, Viegas O, Ratnam S. Effect of Norplant implants on liver, lipid and carbohydrate metabolism. Contraception. 1992;45:141-53.","journal-title":"Contraception"},{"key":"164253_CR36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(89)80001-0","volume":"39","author":"K Singh","year":"1989","unstructured":"Singh K, Viegas O, Liew D, Singh P, Ratnam S. Two year follow-up of changes in clinical chemistry in Singaporean Norplant acceptors: Metabolic changes. Contraception. 1989;39:129-36.","journal-title":"Contraception"},{"key":"164253_CR37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0010-7824(92)90159-Q","volume":"45","author":"K Singh","year":"1992","unstructured":"Singh K, Viegas O, Loke D, Ratnam SS. Effect of Norplant-2 rods on liver lipid and carbohydrate metabolism. Contraception. 1992;45:463-72.","journal-title":"Contraception"},{"key":"164253_CR38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2337\/diab.14.8.473","volume":"14","author":"GW McDonald","year":"1965","unstructured":"McDonald GW, Fisher GF, Burnham C. Reproducibility of the oral glucose tolerance test. Diabetes. 1965;14:473-80.","journal-title":"Diabetes."},{"key":"164253_CR39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0010-7824(95)00016-4","volume":"51","author":"TB Koopersmith","year":"1995","unstructured":"Koopersmith TB, Lobo RA. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive. Contraception. 1995;51:197-200.","journal-title":"Contraception"},{"key":"164253_CR40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0015-0282(16)57479-2","volume":"63","author":"FN Shamma","year":"1995","unstructured":"Shamma FN, Rossi G, HaiHassan L et al. The effect of Norplant on glucose metabolism under hyperglycaemic hyperinsulinaemic conditions. Fertil Steril. 1995;63:767-72.","journal-title":"Fertil Steril."},{"key":"164253_CR41","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0002-9378(89)80014-6","volume":"160","author":"D Shoupe","year":"1989","unstructured":"Shoupe D, Mishell DR. Norplant: Subdermal implant system for long-term contraception. Am J Obstet Gynecol. 1989;160:1286-92.","journal-title":"Am J Obstet Gynecol."},{"key":"164253_CR42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0010-7824(83)90006-9","volume":"27","author":"HB Croxatto","year":"1983","unstructured":"Croxatto HB, Diaz S, Robertson DN, Pavez M. Clinical chemistry in women treated with levonorges-trel implants (Norplant) or a TCu 200 IUD. Contraception. 1983;27:281-8.","journal-title":"Contraception"},{"key":"164253_CR43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0010-7824(95)00011-X","volume":"51","author":"R Mainwaring","year":"1995","unstructured":"Mainwaring R, Hales HA, Stevenson K et al. Metabolic parameter, bleeding and weight changes in US women using progestin only contraceptives. Contraception. 1995;51:149-53.","journal-title":"Contraception"},{"key":"164253_CR44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0010-7824(93)90087-N","volume":"47","author":"JAM Otubu","year":"1993","unstructured":"Otubu JAM, Towobola OA, Aisien AO, Ogunkeye OO. Effects of Norplant contraceptive subdermal implants on serum lipids and lipoproteins. Contraception. 1993;47:149-59.","journal-title":"Contraception"},{"key":"164253_CR45","first-page":"152","volume":"57","author":"KD. Wagner","year":"1996","unstructured":"Wagner KD. Major depression and anxiety disorders associated with Norplant. J Clin Psychiatr. 1996;57:152-7.","journal-title":"J Clin Psychiatr."},{"key":"164253_CR46","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1192\/bjp.115.523.697","volume":"115","author":"A Lewis","year":"1969","unstructured":"Lewis A, Hoghughi M. An evaluation of depression as a side effect of oral contraceptives. Br J Psychiatr. 1969;115:697-701.","journal-title":"Br J Psychiatr."},{"issue":"4","key":"164253_CR47","first-page":"255","volume":"36","author":"SK Chaudhuri","year":"1992","unstructured":"Chaudhuri SK, Chattopadhyay RN, Maitra SK et al. Effects of progesterone on some brain neurotransmitters in intact rats. Ind J Physiol Pharmacol. 1992;36(4):255-8.","journal-title":"Ind J Physiol Pharmacol."},{"key":"164253_CR48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/bmj.3.5621.777","volume":"3","author":"EG Grant","year":"1968","unstructured":"Grant EG, Davies JD. Effect of oral contraceptives on depressive mood changes and on endometrial monoamine oxidase and phosphates. Br Med J. 1968;3:777-80.","journal-title":"Br Med J."},{"key":"164253_CR49","first-page":"500","volume":"6","author":"DV Sheenan","year":"1976","unstructured":"Sheenan DV, Sheenan KH. Psychiatric aspects of oral contraceptive use. Psychiatr Ann. 1976;6:500-8.","journal-title":"Psychiatr Ann."},{"key":"164253_CR50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0010-7824(82)90087-7","volume":"26","author":"M Shaarawy","year":"1982","unstructured":"Shaarawy M, Fayad M, Nagui AR et al. Serotonin metabolism and depression in oral contraceptive users. Contraception. 1982;26:193-204.","journal-title":"Contraception"},{"key":"164253_CR51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-3999(92)90028-Z","volume":"36","author":"M Maes","year":"1992","unstructured":"Maes M, Claes M, Schotte C et al. Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy. J Psychosom Res. 1992;36:191-7.","journal-title":"J Psychosom Res."},{"key":"164253_CR52","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJM199506223322519","volume":"332","author":"JB Alder","year":"1995","unstructured":"Alder JB, Fraunfelder FT. Levonorgestrel implants and intracranial hypertension. N Eng J Med. 1995;332:1720-1.","journal-title":"N Eng J Med."},{"key":"164253_CR53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneur.1993.00540010072020","volume":"50","author":"K Radhakrishnan","year":"1993","unstructured":"Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O'Fallon WM. Idiopathic intracranial hypertension (pseudotumour cerebri): descriptive epidemiology in Rochester, Minn 1976 to 1990. Arch Neurol. 1993;50:78-80.","journal-title":"Arch Neurol."},{"key":"164253_CR54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0889-8588(18)30514-8","volume":"4","author":"P Ruggenenti","year":"1990","unstructured":"Ruggenenti P, Remuzzi G. Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin N Am. 1990;4:219-41.","journal-title":"Hematol Oncol Clin N Am."},{"key":"164253_CR55","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0029-7844(95)00475-0","volume":"87","author":"JL Fraser","year":"1996","unstructured":"Fraser JL, Millenson M, Malynn ER, Uhl L, Kruskall MS. Possible association between the Norplant contraceptive system and thrombotic thrombocytopenic purpura. Obstet Gynaecol. 1996;87:860-3.","journal-title":"Obstet Gynaecol."}],"container-title":["Advances in Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006559124829.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006559124829\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006559124829.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T23:13:26Z","timestamp":1747437206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006559124829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["164253"],"URL":"https:\/\/doi.org\/10.1023\/a:1006559124829","relation":{},"ISSN":["0267-4874","1573-7195"],"issn-type":[{"value":"0267-4874","type":"print"},{"value":"1573-7195","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}